Yaz® Birth Control

RSS
Modified on 2009/10/14 21:47 by admin
Produced by the German pharmaceutical Bayer AG, the new contraceptive pill YAZ ® is under attack by the FDA for false advertisement. Users of the pill should be aware of the fact that claims in YAZ commercials can not be backed, including advertisements that say the drug can treat premenstrual syndrome (PMS) and acne problems. YAZ is proven, however, to treat emotional and physical symptoms of PMDD (Premenstrual Dysphoric Disorder). PMDD is a condition associated with severe emotional and physical problems that are linked closely to the menstrual cycle. The FDA warned Bayer AG in October 2008 that two YAZ advertisements improperly promoted the drug to the general public. The latest judgment between the government agency and Bayer AG requires the drug manufacturer to submit all YAZ television advertisements to the FDA for approval and to comply with all changes suggested by the agency. Most recognizably, the agreement requires Bayer to conduct a $20 million corrective advertising program. Commentators have called this number “chump change”, however, indicating the current trend of big pharmaceuticals consenting to the FDA simply because it is easier compared to actually implementing additional safety measures and drug testing.

The YAZ website has also changed its tune, now indicating their claim about treating acne is not an FDA approved statement: “Yaz is indicated for the treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. YAZ should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control.” Also amended and explained in more detail is the effectiveness of YAZ for treating PMDD. It now says clearly on the homepage that the drug has only been tested in women for 3 menstrual cycles and that YAZ has not been evaluated for the treatment of PMS.

YAZ contains a different kind of hormone from other contraceptives, drsp® (drospirenone), which may increase potassium. Women who take certain drugs should have their potassium levels checked in the first month of taking YAZ. Therefore, you should not take YAZ if you have kidney, liver, or adrenal disease because this could cause serious heart and health problems. It should be noted there have been a number of legal cases brought against Bayer AG concerning YAZ's side effects. Tell you doctor if you are on long-term treatment for a chronic condition such as cardiovascular disease or chronic inflammatory disease and contact help immediately if you experience the following most frequent symptoms (>1%): upper respiratory infection, headache, breast pain, vaginal moniliasis, leukorrhea, diarrhea, nausea, vomiting, vaginitis, abdominal pain, flu syndrome, dysmenorrhea, moniliasis, allergic reaction, urinary tract infection, cystitis, tooth disorder, sore throat, infection, fever, sinusitis, back pain, emotional lability, migraine, suspicious Papanicolaou smear, dyspepsia, rhinitis, acne, gastroenteritis, bronchitis, pharyngitis, skin disorder, intermenstrual bleeding, decreased libido, weight gain, depression, increased cough, dizziness, menstrual disorder, pain in extremity, pelvic pain, and asthenia.
  Name Size